ClinicalTrials.gg
CompletedNCT06925230case seriesUpdated Apr 13, 2025

Arthroscopic Assisted Volar, Dorsal or Combined Capsulodesis in Scapholunate Ligament Injury.

An interventional study of arthroscopic assisted volar scapholunate capsulodesis and arthroscopic assisted dorsal scapholunate capsulodesis in Scapholunate Interosseous Ligament Injury and SLLI, sponsored by Ain Shams University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-04-13.

Sponsored by Ain Shams University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years after the study started (first participant enrolled Mar 2023, registered Apr 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this case series study is to test the efficacy of arthroscopic assisted volar, dorsal or combined scapholunate capsulodesis in the management of scapholunate ligament injuries.

Read the detailed description

The aim of this case series study is to test the efficacy of arthroscopic assisted volar, dorsal or combined scapholunate capsulodesis in the management of scapholunate ligament injuries. All patients will be assessed preoperatively by careful history taking , full general and local examination and radiological evaluation using wrist plain X-rays (Standard PA, clenched-fist PA , PA in ulnar deviation , lateral projection in neutral ,flexion and extension ) and wrist Magnetic resonance imaging.an informed written consent was taken before any surgery. The procedure starts with a standard radiocarpal and then midcarpal arthroscopy. During the arthroscopic examination ,several factors are assessed, including the location of the SLIL injury (volar, membranous, dorsal, or complete), the condition of the cartilage, the reducibility of the carpus, and other associated pathologies like TFCC injury. Classification is done using Geissler Classification, Garcia Elias Classification and EWAS classification.Volar capsulodesis using Hayman Lui et al or Del Pinal et al method and/or dorsal capsulodesis using original Mathoulin technique or combined capsulodesis were done.

02

Conditions studied

  • Scapholunate Interosseous Ligament Injury
  • SLLI
03

In context

Lead sponsor

Ain Shams University is the lead sponsor of 1,932 studies on the registry; 433 are open to participants now.

Of its 33 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Sex: both sexes.
  • Age: above 18 years
  • Lesion: subacute or chronic scapholunate ligament injury
  • partial and complete SLIL tears

Exclusion criteria

Exclusion Criteria:

  • Acute scapholunate ligament injury
  • irreducible carpal malalignment
  • posttraumatic arthritis
  • associated fractures that could affect the functional outcome
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
14 participants (actual)

Study arms

  • Other
    arthroscopic assisted volar scapholunate capsulodesis

    arthroscopic assisted combined volar capsulodesis using PDS 2.00 sutures

    Procedure: arthroscopic assisted volar scapholunate capsulodesis · Procedure: arthroscopic assisted dorsal scapholunate capsulodesis · Procedure: arthroscopic assisted combined volar and dorsal scapholunate capsulodesis

Interventions

  • Procedurearthroscopic assisted volar scapholunate capsulodesis

    arthroscopic assisted volar scapholunate capsulodesis using PDS 2.00 sutures

    Also known as: volar scapholunate capsuloligamentodesis

  • Procedurearthroscopic assisted dorsal scapholunate capsulodesis

    arthroscopic assisted dorsal scapholunate capsulodesis using PDS 2.00 sutures

  • Procedurearthroscopic assisted combined volar and dorsal scapholunate capsulodesis

    arthroscopic assisted combined volar and dorsal scapholunate capsulodesis using PDS 2.00 sutures

06

What researchers measure

Primary outcomes

  1. wrist range of motion

    wrist range of motion degrees in flexion , extension, radial deviation and ulnar deviation.

    Time frame: preoperative and postoperative after 3months , 6months , 9months and 12months

Secondary outcomes

  1. scapholunate gap

    scapholunate gap in PA wrist plain Xray is the distance between middle of scaphoid and middle of lunate bones in PA wrist plain Xray in millimeters

    Time frame: preoperative and postoperative scapholunate gaps after 3months , 6months , 9months and 12months

07

Study locations

1 site
  • Ain Shams University
    Cairo, Abbassia 00000, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 13, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06925230
Responsible party
Sponsor
First posted
Apr 13, 2025
Start date
Mar 15, 2023
Primary completion
Mar 10, 2025
Completion
Mar 10, 2025
Last update
Apr 13, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion